PPA
AXSM icon

Parametric Portfolio Associates’s Axsome Therapeutics AXSM Stock Holding History

Parametric Portfolio Associates’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.46M Sell
35,194
-10,984
-24% -$340K ﹤0.01% 2586
2021
Q4 		$1.75M Buy
46,178
+20,060
+77% +$738K ﹤0.01% 2512
2021
Q3 		$861K Buy
26,118
+11,861
+83% +$462K ﹤0.01% 2866
2021
Q2 		$962K Buy
14,257
+1,663
+13% +$99.8K ﹤0.01% 2789
2021
Q1 		$713K Sell
12,594
-11,167
-47% -$786K ﹤0.01% 3315
2020
Q4 		$1.94M Buy
23,761
+5,068
+27% +$379K ﹤0.01% 2672
2020
Q3 		$1.33M Sell
18,693
-6,009
-24% -$468K ﹤0.01% 2737
2020
Q2 		$2.03M Buy
24,702
+4,165
+20% +$321K ﹤0.01% 2495
2020
Q1 		$1.21M Sell
20,537
-6,561
-24% -$535K ﹤0.01% 2691
2019
Q4 		$2.8M Sell
27,098
-24,730
-48% -$999K ﹤0.01% 2466
2019
Q3 		$1.05M Sell
51,828
-11,553
-18% -$297K ﹤0.01% 3001
2019
Q2 		$1.63M Sell
63,381
-29,476
-32% -$591K ﹤0.01% 2793
2019
Q1 		$1.32M Buy
+92,857
New +$862K ﹤0.01% 2885

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Parametric Portfolio Associates's AXSM Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Axsome Therapeutics (AXSM) stake by 24% in Q1 2022, selling an estimated $340K and leaving 35,194 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

Parametric Portfolio Associates first reported a position in AXSM in Q1 2019 and has held it in 13 quarters since. The position peaked at $2.8M in Q4 2019. 175 funds tracked by Wall St. Rank hold AXSM as of Q1 2022.

  • Parametric Portfolio Associates held 35,194 shares of Axsome Therapeutics worth $1.46M as of Q1 2022.
  • Parametric Portfolio Associates sold 10,984 Axsome Therapeutics shares in Q1 2022, an estimated $340K.
  • Axsome Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2586 holding.
  • Parametric Portfolio Associates first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 13 quarters since.
  • Parametric Portfolio Associates's Axsome Therapeutics position peaked at $2.8M in Q4 2019.
  • 175 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.